Red Light Intervention for Myopia Prevention

A Randomized Controlled Trial of Low-dose Single-wavelength Red Light in the Decrease of Myopia Incidence Rate in the Setting of School.

To explore the effectiveness of using low-intensity single-wavelength red light to prevent myopia in schoolchildren, and to provide a feasible scheme for reducing the incidence of myopia.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

278

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200040
        • Xiangui He

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 11 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Students of grade 1-4 in the participating schools;
  • Students' eyes have no myopia, that is the cycloplegic spherical equivalent(SE) >-0.50D, and at least one eye accords with the pre-myopic state, that is -0.50D <cycloplegic SE≤0.50D;
  • Students whose mother and/or father are in myopia status (SE < -3.0D for either of eyes);
  • Students whose parents sign informed consent and agree to let their kids participate in baseline screen and follow-up examinations and surveys.

Exclusion Criteria:

  • Students whose parents do not sign informed consent;
  • Students who have strabismus and/or other binocular vision abnormality;
  • Students who have other eye diseases and/or systematic diseases;
  • Students who have DC <=-1.5D;
  • Students whose difference of SE between the two eyes >=1.5D;
  • Students who meet the standards with which investigators and study physicians think it is not appropriate to enroll.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
No intervention
Experimental: Intervention
Red light irradiation was conducted at school from Monday to Friday and at home everyday in summer and winter holiday twice a day for 3 minutes per time, with an interval of 4 hours
2 times a day, 3 minutes each time, with an interval of more than 4 hours. During the semester: From Monday to Friday, set up an intervention room in the school; For winter and summer vacation: everyday at home

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
One-year cumulative incidence of myopia (%) in the intervention group and the control group.
Time Frame: 1 year
Myopia is defined as the cycloplegic spherical equivalent of either eye ≤-0.5D
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The progress of spherical equivalent(SE,D) of children in intervention group and control group.
Time Frame: 1 year
The spherical equivalent(SE,D) will be measured by autorefractor(KR-8900, Topcon).
1 year
The progress of axial length of children in intervention group and control group.
Time Frame: 1 year
The axial length will be measured using IOLMaster.
1 year
The progress of choroidal thickness in children in pre-myopia state in intervention group and control group.
Time Frame: 1 year
The choroidal thickness will be measured using SS-OCT.
1 year
The change of uncorrected visual acuity (UCVA) of children in intervention group and control group.
Time Frame: 1 year
The uncorrected visual acuity (UCVA) will be measured using a mounted and illuminated E chart of the Early Treatment Diabetic Retinopathy study (ETDRS) charts.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Xiangui He, Shanghai Eye Disease Prevention and Treatment Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 25, 2021

Primary Completion (Actual)

August 31, 2022

Study Completion (Actual)

August 31, 2022

Study Registration Dates

First Submitted

March 24, 2021

First Submitted That Met QC Criteria

March 29, 2021

First Posted (Actual)

April 1, 2021

Study Record Updates

Last Update Posted (Actual)

September 30, 2022

Last Update Submitted That Met QC Criteria

September 28, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SHYB2021001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on LLLT(Low Level Laser Therapy)

Subscribe